Home
Conditions
Colonic Neoplasms

Clinical trial condition

Colonic Neoplasms

Explore clinical trials studying Colonic Neoplasms. Study availability and eligibility vary by location and protocol.

1,629 public trials 244 recruiting studies

Refine in advanced search Browse all conditions

Colonic Neoplasms trial results

Completed

Studying a Quality of Life Questionnaire in Patients With Colorectal Cancer

NCT00564694

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Cancer, +11 more
Locations: Centre Alexis Vautrin Vandœuvre-lès-Nancy, France

Charite University Medical Center of Berlin Berlin, Germany

Klinikum der Universitaet Regensburg Regensburg, Germany

Basingstoke and North Hampshire NHS Foundation Trust Basingstoke, England, United Kingdom

View Trial Details

Completed

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

NCT00096083

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenoma, +63 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States

View Trial Details

Completed

GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer

NCT00262808

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Cancer, +10 more
Locations: James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States

Duke Comprehensive Cancer Center Durham, North Carolina, United States

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Stage III Colon Cancer

NCT00003835

Conditions: Adenocarcinoma of the Colon, Colonic Diseases, Colonic Neoplasms, +10 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer

NCT00060411

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +26 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

NCT00031681

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Adult Primary Liver Cancer, +182 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors

NCT00138177

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +17 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

NCT00026299

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Cancer, +11 more
Locations: University of Chicago Cancer Research Center Chicago, Illinois, United States

Louis A. Weiss Memorial Hospital Chicago, Illinois, United States

Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States

Evanston Northwestern Health Care Evanston, Illinois, United States

View Trial Details

Completed

BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer

NCT00022477

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Cancer, +11 more
Locations: University of Illinois at Chicago Chicago, Illinois, United States

University of Chicago Cancer Research Center Chicago, Illinois, United States

Louis A. Weiss Memorial Hospital Chicago, Illinois, United States

Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States

View all 15 locations

View Trial Details

Completed

Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer

NCT00112918

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Cancer, +10 more
Locations: Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States

View Trial Details

Colonic Neoplasms

Colonic Neoplasms trial results

Related conditions